Arix Bioscience
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Arix Bioscience's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 67% to $112,000. The net income raised on -$27,575,000 and profit margin reached -24621%. Total operating expenses were $5,405,000.
Profit Margin
| 2016 | 0 | 0 | |
|---|---|---|---|
| 2017 | 1.85M | -7.46M | -402.21% |
| 2018 | 1.32M | 36.87M | 2776.96% |
| 2019 | 506K | -69.68M | -13771.74% |
| 2020 | 477K | 395.04M | 82818.24% |
| 2021 | 340K | -173.11M | -50915.59% |
| 2022 | 112K | -27.57M | -24620.54% |
ARIX.L Income Statement (2016 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 112K | 340K | 477K | 506K | 1.32M | 1.85M | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 112K | 340K | 477K | 506K | 1.32M | 1.85M | 0 |
Operating exp. | |||||||
Research and development | 0 | 0 | 0 | 0 | 0 | 208K | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 5.40M | 4.80M | 7.78M | 12.49M | 15.03M | 14.64M | 0 |
Operating income | 25.47M | 50.94M | -142.44M | 46.64M | 40.80M | -3.58M | 0 |
Other income (expenses), net | -53.05M | -112.02M | -1.68M | -122.21M | 1.95M | -447K | 0 |
Income before tax | -27.57M | -61.08M | 126.30M | -75.56M | 42.76M | -7.69M | 0 |
Income tax expense | -4K | 112.02M | -268.74M | -5.88M | 5.88M | -221K | 0 |
Net income | -27.57M | -173.11M | 395.04M | -69.68M | 36.87M | -7.46M | 0 |
Earnings per share | |||||||
Basic EPS | -0.21 | -1.27 | 2.78 | -0.54 | 0.29 | -0.09 | 0 |
Diluted EPS | -0.21 | -1.27 | 2.78 | -0.54 | 0.29 | -0.09 | 0 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |